Predictive factors for early progression during induction chemotherapy (IC) and chemotherapy-free interval (CFI): Analysis from PRODIGE 9 trial - Université de Bourgogne Accéder directement au contenu
Communication Dans Un Congrès Année : 2017

Predictive factors for early progression during induction chemotherapy (IC) and chemotherapy-free interval (CFI): Analysis from PRODIGE 9 trial

T. Aparicio
  • Fonction : Auteur
V. Boige
  • Fonction : Auteur
C. Borel
  • Fonction : Auteur

Domaines

Cancer

Dates et versions

hal-01626216 , version 1 (30-10-2017)

Identifiants

Citer

T. Aparicio, J. Bennouna, K. Le Malicot, V. Boige, J. Taieb, et al.. Predictive factors for early progression during induction chemotherapy (IC) and chemotherapy-free interval (CFI): Analysis from PRODIGE 9 trial. The 42nd european society for medical oncology Congress, Sep 2017, Madrid, Spain. pp.557P, ⟨10.1093/annonc/mdx393.083⟩. ⟨hal-01626216⟩
85 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More